These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

149 related articles for article (PubMed ID: 11263445)

  • 21. CD38: an 'orphan' protein that may be finding a home?
    Felgar RE
    Leuk Res; 2000 Feb; 24(2):161-2. PubMed ID: 10654452
    [No Abstract]   [Full Text] [Related]  

  • 22. Mutational status of IgVH genes consistent with antigen-driven selection but not percent of mutations has prognostic impact in B-cell chronic lymphocytic leukemia.
    Degan M; Rupolo M; Bo MD; Stefanon A; Bomben R; Zucchetto A; Canton E; Berretta M; Nanni P; Steffan A; Ballerini PF; Damiani D; Pucillo C; Attadia V; Colombatti A; Gattei V
    Clin Lymphoma; 2004 Sep; 5(2):123-6. PubMed ID: 15453928
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Spontaneous immunoglobulin-producing capacity of cultures from lupus patients and normal donors following depletion of cells expressing CD19 or CD38.
    Bourne T; Zukowska-Cooper M; Salaman MR; Seifert MH; Isenberg DA
    Clin Exp Immunol; 1998 Mar; 111(3):611-6. PubMed ID: 9528907
    [TBL] [Abstract][Full Text] [Related]  

  • 24. The immunophenotype of minimally differentiated acute myeloid leukemia (AML-M0): reduced immunogenicity and high frequency of CD34+/CD38- leukemic progenitors.
    Costello R; Mallet F; Chambost H; Sainty D; Arnoulet C; Gastaut JA; Olive D
    Leukemia; 1999 Oct; 13(10):1513-8. PubMed ID: 10516751
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Conversion of CD38 and/or myeloid-associated marker expression status during the course of B-CLL: association with a change to an aggressive clinical course.
    Chang CC; Cleveland RP
    Blood; 2002 Aug; 100(3):1106. PubMed ID: 12150158
    [No Abstract]   [Full Text] [Related]  

  • 26. Stimulation of ADP-ribosyl cyclase activity of the cell surface antigen CD38 by zinc ions resulting from inhibition of its NAD+ glycohydrolase activity.
    Kukimoto I; Hoshino S; Kontani K; Inageda K; Nishina H; Takahashi K; Katada T
    Eur J Biochem; 1996 Jul; 239(1):177-82. PubMed ID: 8706705
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Thrombin induces the association of cyclic ADP-ribose-synthesizing CD38 with the platelet cytoskeleton.
    Torti M; Festetics ET; Bertoni A; Sinigaglia F; Balduini C
    FEBS Lett; 1998 May; 428(3):200-4. PubMed ID: 9654134
    [TBL] [Abstract][Full Text] [Related]  

  • 28. CD38 in hematopoietic malignancies.
    Konopleva M; Rissling I; Andreeff M
    Chem Immunol; 2000; 75():189-206. PubMed ID: 10851785
    [No Abstract]   [Full Text] [Related]  

  • 29. 3rd CD38 International Workshop. Paris, France, October 23-25, 1997. Abstracts.
    J Biol Regul Homeost Agents; 1997; 11 Suppl 1():1-52. PubMed ID: 9476526
    [No Abstract]   [Full Text] [Related]  

  • 30. CD34high+ CD38(low/-) cells generated in a xenogenic coculture system are capable of both long-term hematopoiesis and multiple differentiation.
    Tsuji T; Itoh K; Nishimura-Morita Y; Watanabe Y; Hirano D; Mori KJ; Yatsunami K
    Leukemia; 1999 Sep; 13(9):1409-19. PubMed ID: 10482993
    [TBL] [Abstract][Full Text] [Related]  

  • 31. CD38 in hematopoiesis.
    Campana D; Suzuki T; Todisco E; Kitanaka A
    Chem Immunol; 2000; 75():169-88. PubMed ID: 10851784
    [No Abstract]   [Full Text] [Related]  

  • 32. Retinoid-mediated signaling in CD38 antigen expression.
    Mehta K
    Chem Immunol; 2000; 75():20-38. PubMed ID: 10851777
    [No Abstract]   [Full Text] [Related]  

  • 33. Increased CD38 expression is associated with favorable prognosis in adult acute leukemia.
    Keyhani A; Huh YO; Jendiroba D; Pagliaro L; Cortez J; Pierce S; Pearlman M; Estey E; Kantarjian H; Freireich EJ
    Leuk Res; 2000 Feb; 24(2):153-9. PubMed ID: 10654451
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Transforming growth factor-beta(1) induces apoptosis in CD34(+)CD38(-/low) cells that express Bcl-2 at a low level.
    Xiao M; Oppenlander BK; Dooley DC
    Exp Hematol; 2001 Sep; 29(9):1098-108. PubMed ID: 11532351
    [TBL] [Abstract][Full Text] [Related]  

  • 35. CD38 in health and disease.
    Bofill M; Borthwick NJ
    Chem Immunol; 2000; 75():218-34. PubMed ID: 10851787
    [No Abstract]   [Full Text] [Related]  

  • 36. Peripheral blood CD38 expression predicts time to progression in B-cell chronic lymphocytic leukemia after first-line therapy with high-dose chlorambucil.
    Morabito F; Mangiola M; Stelitano C; Deaglio S; Callea V; Malavasi F
    Haematologica; 2002 Feb; 87(2):217-8. PubMed ID: 11836173
    [TBL] [Abstract][Full Text] [Related]  

  • 37. CD38/ADP-ribosyl cyclase: A new role in the regulation of osteoclastic bone resorption.
    Sun L; Adebanjo OA; Moonga BS; Corisdeo S; Anandatheerthavarada HK; Biswas G; Arakawa T; Hakeda Y; Koval A; Sodam B; Bevis PJ; Moser AJ; Lai FA; Epstein S; Troen BR; Kumegawa M; Zaidi M
    J Cell Biol; 1999 Sep; 146(5):1161-72. PubMed ID: 10477767
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Topology of CD38.
    De Flora A; Franco L; Guida L; Bruzzone S; Usai C; Zocchi E
    Chem Immunol; 2000; 75():79-98. PubMed ID: 10851780
    [No Abstract]   [Full Text] [Related]  

  • 39. Expansion of human cord blood CD34(+)CD38(-) cells in ex vivo culture during retroviral transduction without a corresponding increase in SCID repopulating cell (SRC) frequency: dissociation of SRC phenotype and function.
    Dorrell C; Gan OI; Pereira DS; Hawley RG; Dick JE
    Blood; 2000 Jan; 95(1):102-10. PubMed ID: 10607692
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Longitudinal dynamics of antigen-specific CD8+ cytotoxic T lymphocytes following primary Epstein-Barr virus infection.
    Bharadwaj M; Burrows SR; Burrows JM; Moss DJ; Catalina M; Khanna R
    Blood; 2001 Oct; 98(8):2588-9. PubMed ID: 11665684
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 8.